GLYMUCH
LIVE

Serial Number

79394082

Owner

KH Neochem Co., Ltd.

Attorney

Matthew Saunders

Filing Date

Feb 29, 2024

Add to watchlist:

No watchlists yet
View on USPTO

GLYMUCH Trademark

Serial Number: 79394082 • Registration: 7699935

GLYMUCH is a trademark filed by KH Neochem Co., Ltd. on February 29, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

KH Neochem Co., Ltd. (4 trademarks)

2-3-1 Nihonbashi-Muromachi,

Entity Type: 03

Trademark Details

Filing Date

February 29, 2024

Registration Date

February 25, 2025

Published for Opposition

January 7, 2025

Goods & Services

Glycan for use in the manufacture of pharmaceuticals, chemicals, foods, cosmetics and reagents; glycopeptide for use in the manufacture of pharmaceuticals, chemicals, foods, cosmetics and reagents; glycoprotein for use in the manufacture of pharmaceuticals, chemicals, foods, cosmetics and reagents; protein for industrial use; enzymes for industrial purposes; glyco reagents for use in the manufacture of pharmaceuticals, chemicals, foods, cosmetics and reagents; diagnostic reagents for scientific or research use; biological preparations, other than for medical or veterinary purposes; chemicals for use in industry and science

Diagnostic reagents for medical use.

Research, testing and analysis services in the field of the use of glycan or glycopeptides in the manufacture of pharmaceuticals, chemicals, foods, cosmetics, and reagents; chemistry consultation services; research and development of new products for others

Custom manufacture of glycan or glycopeptides; custom manufacture of protein for industrial use; custom manufacture of chemicals for use in industry and science; custom manufacture of biopharmaceuticals.

Biochips for research or scientific purposes; laboratory apparatus and instruments for synthesizing and analyzing N-glycan structures for use in biotherapeutics research, API manufacturing and diagnosis, not for medical use

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 10, 2025 OPNX
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 27, 2025 FINO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 24, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 24, 2025 OPNR
FINAL DISPOSITION NOTICE SENT TO IB
Sep 4, 2025 FICS
FINAL DISPOSITION PROCESSED
Sep 4, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 26, 2025 FICR
NEW REPRESENTATIVE AT IB RECEIVED
May 23, 2025 NREP
NEW REPRESENTATIVE AT IB RECEIVED
May 2, 2025 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Apr 25, 2025 NREP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 25, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 25, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 7, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jan 7, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 1, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 23, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 22, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 22, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 22, 2024 TROA
REFUSAL PROCESSED BY IB
Oct 7, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 19, 2024 RFCS
REFUSAL PROCESSED BY MPU
Sep 19, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 18, 2024 RFCR
NON-FINAL ACTION WRITTEN
Sep 17, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 16, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
May 7, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 7, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 25, 2024 REPR